Clinical Trials Using CD19CAR-CD28zeta-4-1BB-expressing Allogeneic T Lymphocytes

Clinical trials are research studies that involve people. The clinical trials on this list are studying CD19CAR-CD28zeta-4-1BB-expressing Allogeneic T Lymphocytes. All trials on the list are supported by NCI.

NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.

Trial 1 of 1
  • CD19.CAR T Cells in Treating Participants with CD19 Positive Malignancies after Stem Cell Transplant

    This phase I trial studies the side effects and best dose of CD19.CAR T cells in treating participants with CD19 positive malignancies after stem cell transplant. T cells, also called T lymphocytes, are special infection-fighting blood cells that can kill other cells including tumor cells. T lymphocytes, such as CD19.CAR T cells, may kill tumor cells but there normally are not enough of them to kill all the tumor cells.
    Location: 3 locations